Dassault Systemes Could Face Investor Skepticism over Potential Acquisition

Dow Jones07-20

0643 GMT - Dassault Systemes' potential acquisition of drug-trial software maker ArisGlobal could be met with investor skepticism, Citi's Balajee Tirupati and Pavan Daswani say in a research note. The Financial Times reported last week that the French software company was in talks with Nordic Capital to buy ArisGlobal for about $2 billion. Nordic Capital declined to comment when approached by Dow Jones Newswires, and Dassault Systemes didn't respond to a request for comment. A potential acquisition would be consistent with Dassault Systemes' strategy, extending the platform of its Medidata life-sciences tech business at a time the market is evolving with artificial intelligence, Citi says. However, investors have favored direct returns over acquisitions, and a deal would expand Dassault Systemes' presence in a market where growth has been constrained, the analysts say. (adria.calatayud@wsj.com)

(END) Dow Jones Newswires

July 20, 2026 02:45 ET (06:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2652260493?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 14:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652260493","market":"hk","top_or_hot":-1,"title":"Dassault Systemes Could Face Investor Skepticism over Potential Acquisition","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0643 GMT - Dassault Systemes' potential acquisition of drug-trial software maker ArisGlobal could be met with investor skepticism, Citi's Balajee Tirupati and Pavan Daswani say in a research note. The Financial Times reported last week that the French software company was in talks with Nordic Capital to buy ArisGlobal for about $2 billion. Nordic Capital declined to comment when approached by Dow Jones Newswires, and Dassault Systemes didn't respond to a request for comment. A potential acquisition would be consistent with Dassault Systemes' strategy, extending the platform of its <a href=\"https://laohu8.com/S/MDSO\">Medidata</a> life-sciences tech business at a time the market is evolving with artificial intelligence, Citi says. However, investors have favored direct returns over acquisitions, and a deal would expand Dassault Systemes' presence in a market where growth has been constrained, the analysts say. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 20, 2026 02:45 ET (06:45 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dassault Systemes Could Face Investor Skepticism over Potential Acquisition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDassault Systemes Could Face Investor Skepticism over Potential Acquisition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-20 14:45</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0643 GMT - Dassault Systemes' potential acquisition of drug-trial software maker ArisGlobal could be met with investor skepticism, Citi's Balajee Tirupati and Pavan Daswani say in a research note. The Financial Times reported last week that the French software company was in talks with Nordic Capital to buy ArisGlobal for about $2 billion. Nordic Capital declined to comment when approached by Dow Jones Newswires, and Dassault Systemes didn't respond to a request for comment. A potential acquisition would be consistent with Dassault Systemes' strategy, extending the platform of its <a href=\"https://laohu8.com/S/MDSO\">Medidata</a> life-sciences tech business at a time the market is evolving with artificial intelligence, Citi says. However, investors have favored direct returns over acquisitions, and a deal would expand Dassault Systemes' presence in a market where growth has been constrained, the analysts say. (adria.calatayud@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 20, 2026 02:45 ET (06:45 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4023","symbol_name":"应用软件","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2652260493","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652260493","pubTimestamp":1784529900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0643 GMT - Dassault Systemes' potential acquisition of drug-trial software maker ArisGlobal could be met with investor skepticism, Citi's Balajee Tirupati and Pavan Daswani say in a research note. The Financial Times reported last week that the French software company was in talks with Nordic Capital to buy ArisGlobal for about $2 billion. Nordic Capital declined to comment when approached by Dow Jones Newswires, and Dassault Systemes didn't respond to a request for comment. A potential acquisition would be consistent with Dassault Systemes' strategy, extending the platform of its Medidata life-sciences tech business at a time the market is evolving with artificial intelligence, Citi says. However, investors have favored direct returns over acquisitions, and a deal would expand Dassault Systemes' presence in a market where growth has been constrained, the analysts say.  Dow Jones NewswiresJuly 20, 2026 02:45 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4023":"应用软件","DASTY":"Dassault Systemes SA"},"translate_title":"达索系统公司可能面临投资者对潜在收购的怀疑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DASTY":0.9},"content_text":"0643 GMT - Dassault Systemes' potential acquisition of drug-trial software maker ArisGlobal could be met with investor skepticism, Citi's Balajee Tirupati and Pavan Daswani say in a research note. The Financial Times reported last week that the French software company was in talks with Nordic Capital to buy ArisGlobal for about $2 billion. Nordic Capital declined to comment when approached by Dow Jones Newswires, and Dassault Systemes didn't respond to a request for comment. A potential acquisition would be consistent with Dassault Systemes' strategy, extending the platform of its Medidata life-sciences tech business at a time the market is evolving with artificial intelligence, Citi says. However, investors have favored direct returns over acquisitions, and a deal would expand Dassault Systemes' presence in a market where growth has been constrained, the analysts say. (adria.calatayud@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 20, 2026 02:45 ET (06:45 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2652260493","isCrawlerRequest":true}